2016
Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes
HEGER, Zbynek; Hana POLANSKÁ; Miguel Angel Merlos RODRIGO; Roman GURÁŇ; Pavel KULICH et al.Základní údaje
Originální název
Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes
Autoři
HEGER, Zbynek; Hana POLANSKÁ; Miguel Angel Merlos RODRIGO; Roman GURÁŇ; Pavel KULICH; Pavel KOPEL; Michal MASAŘÍK; Tomas ECKSCHLAGER; Marie STIBOROVA; Rene KIZEK a Vojtech ADAM
Vydání
Scientific Reports, London, Nature Publishing Group, 2016, 2045-2322
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.259
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/16:00090895
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
CANCER PROGRESSION; CELL-LINE; IN-VITRO; METALLOTHIONEIN; EXPRESSION; THERAPY; PROTEIN; URINE; NANOPARTICLES; TRAFFICKING
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 10. 2016 12:17, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Herein, we describe the preparation of liposomes with folate-targeting properties for the encapsulation of anti-sarcosine antibodies (antisarAbs@LIP) and sarcosine (sar@LIP). The competitive inhibitory effects of exogenously added folic acid supported the role of folate targeting in liposome internalization. We examined the effects of repeated administration on mice PC-3 xenografts. Sar@LIP treatment significantly increased tumor volume and weight compared to controls treated with empty liposomes. Moreover, antisarAbs@LIP administration exhibited a mild antitumor effect. We also identified differences in gene expression patterns post-treatment. Furthermore, Sar@LIP treatment resulted in decreased amounts of tumor zinc ions and total metallothioneins. Examination of the spatial distribution across the tumor sections revealed a sarcosine-related decline of the MT1X isoform within the marginal regions but an elevation after antisarAbs@LIP administration. Our exploratory results demonstrate the importance of sarcosine as an oncometabolite in PCa. Moreover, we have shown that sarcosine can be a potential target for anticancer strategies in management of PCa.
Návaznosti
| LQ1601, projekt VaV |
|